Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06774430 · ClinicalTrials.gov registry record

Digital Strategies to Advance Help-Seeking Aim 1 and 2

A clinical trial of First Episode Psychosis and Clinical High-Risk, sponsored by Columbia University.

Recruiting
Registry status
25,000
Enrollment target
1
Study location

NCT06774430 is a study of First Episode Psychosis and Clinical High-Risk that is actively recruiting participants, run by Columbia University. The registered enrollment target is 25,000 participants, above the 3,308-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (656% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06774430, a study of First Episode Psychosis and Clinical High-Risk, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
25,000 participants
Enrollment target
1
Study location

Study Summary

This proposal aims to establish a Digital Laboratory focused on advancing help-seeking and expediting treatment initiation in youth ages 12-29 who are at Clinical High-Risk (CHR) for developing psychosis. Leveraging the Health Action Process Approach (HAPA) model, this study will identify help-seeking subtypes in 25,000 youth who screen positive for psychosis-risk on Mental Health America's national online screening platform, iteratively develop and test theory and data-driven, personalized strategies to advance help-seeking using Micro-Randomized Trials and a Sequential Multiple Assignment Randomized Trial, identify the most accurate CHR screening threshold in an online environment, and link youth, when indicated, to local clinical care via Accelerating Medicines Partnership - Schizophrenia (AMP-SCZ), a NIH funded national network of CHR programs throughout the US. This academic-industry partnership aims to curate one of the largest datasets of youth with CHR, and to develop effective strategies to enhance early help-seeking, in a population where help-seeking is critical and a significant barrier to care.

Conditions Studied

First Episode Psychosis Clinical High-Risk Early Psychosis

Study Locations (1)

New York

  • Columbia University Irving Medical Center - New York

Trial Details

FieldValue
Enrollment Target 25,000 participants
Start Date 2025-04-07
Est. Completion 2028-05-31

Sponsor

Columbia University

958 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06774430

The ClinicalTrials.gov registry entry for NCT06774430 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,308-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (656% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with First Episode Psychosis appearing as the primary indexed condition, and to 0 interventions.

NCT06774430 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06774430 about?

NCT06774430 is a clinical study titled "Digital Strategies to Advance Help-Seeking Aim 1 and 2". This proposal aims to establish a Digital Laboratory focused on advancing help-seeking and expediting treatment initiation in youth ages 12-29 who are at Clinical High-Risk (CHR) for developing psychosis. Leveraging the Health Action Process Approach (HAPA) model, this study will identify help-seeki...

What is the current status of trial NCT06774430?

This trial is currently recruiting. The enrollment target is 25,000 participants. The study started on 2025-04-07. Estimated completion is 2028-05-31.

What conditions does trial NCT06774430 study?

This clinical trial studies the following conditions: First Episode Psychosis, Clinical High-Risk, Early Psychosis.

Who is sponsoring clinical trial NCT06774430?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06774430 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for First Episode Psychosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

First Episode Psychosis

All registered trials for this condition

Clinical High-Risk

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.